G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $570,000 | +45.0% | 45,605 | -42.7% | 0.09% | +145.7% |
| Q2 2022 | $393,000 | -64.9% | 79,537 | +55.7% | 0.04% | -52.7% |
| Q2 2021 | $1,121,000 | -49.6% | 51,094 | -44.7% | 0.07% | -53.8% |
| Q1 2021 | $2,223,000 | +25.2% | 92,406 | -6.4% | 0.16% | +33.3% |
| Q4 2020 | $1,776,000 | +9.9% | 98,725 | -29.4% | 0.12% | +12.1% |
| Q3 2020 | $1,616,000 | +62.7% | 139,924 | +242.0% | 0.11% | +57.4% |
| Q2 2020 | $993,000 | – | 40,919 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |